Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
Banks take advantage of Fed crisis lending programs
Financial institutions took about $300 billion in short-term loans this week from the Federal Reserve as the industry copes with a serious crisis.
One year after the first rate hike, the Fed stands at policy crossroads
The Fed in some ways is both closer and further away from its goals when it first started raising rates.
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
Paxlovid is recommended for people over 50 or those with medical conditions such as high blood pressure or diabetes that place them at a greater risk of Covid.
Microsoft tries to justify A.I.’s tendency to give wrong answers by saying they’re ‘usefully wrong’
Current AI technologies like ChatGPT can often produce inaccurate responses, which presents a problem as Microsoft adds AI to Word, Excel, and other products.
Citigroup’s top ideas from here for the next 12 months
Citi added four new buy names to its focus list as the market enters a new period of volatility.
Google raises price of YouTube TV to $73 a month, blaming content costs
YouTube TV is Google’s cable replacement. It provides access to live TV and cable channels, delivered through an internet connection.
Wells Fargo upgraded this oil refiner that could rally more than 20%
The Wall Street firm upgraded the stock to overweight from equal weight.
These 12 stocks are holding up despite the banking crisis and are expected to keep doing well
Despite the recent sharp swings in the market, there are some stocks are holding up.
Microsoft adds OpenAI technology to Word and Excel
Microsoft plans to improve its Office 365 suite of business software with ChatGPT-like generative A.I. tech.
